Thorne S - Search Results

1

Importance of glycolysis and oxidative phosphorylation in advanced melanoma.

Ho J, de Moura MB, Lin Y, Vincent G, Thorne S, Duncan LM, Hui-Min L, Kirkwood JM, Becker D, Van Houten B, Moschos SJ. Ho J, et al. Among authors: thorne s. Mol Cancer. 2012 Oct 9;11:76. doi: 10.1186/1476-4598-11-76. Mol Cancer. 2012. PMID: 23043612 Free PMC article.

2

Oncolytic vaccinia virus demonstrates antiangiogenic effects mediated by targeting of VEGF.

Hou W, Chen H, Rojas J, Sampath P, Thorne SH. Hou W, et al. Int J Cancer. 2014 Sep 1;135(5):1238-46. doi: 10.1002/ijc.28747. Epub 2014 Feb 18. Int J Cancer. 2014. PMID: 24474587 Free PMC article.

3

Withaferin A inhibits in vivo growth of breast cancer cells accelerated by Notch2 knockdown.

Kim SH, Hahm ER, Arlotti JA, Samanta SK, Moura MB, Thorne SH, Shuai Y, Anderson CJ, White AG, Lokshin A, Lee J, Singh SV. Kim SH, et al. Breast Cancer Res Treat. 2016 May;157(1):41-54. doi: 10.1007/s10549-016-3795-y. Epub 2016 Apr 21. Breast Cancer Res Treat. 2016. PMID: 27097807 Free PMC article.

4

An IRF2-Expressing Oncolytic Virus Changes the Susceptibility of Tumor Cells to Antitumor T Cells and Promotes Tumor Clearance.

Shao L, Srivastava R, Delgoffe GM, Thorne SH, Sarkar SN. Shao L, et al. Cancer Immunol Res. 2024 Jun 4;12(6):779-790. doi: 10.1158/2326-6066.CIR-23-0573. Cancer Immunol Res. 2024. PMID: 38517470

5

Design and testing of novel oncolytic vaccinia strains.

Thorne SH. Thorne SH. Methods Mol Biol. 2009;542:635-47. doi: 10.1007/978-1-59745-561-9_32. Methods Mol Biol. 2009. PMID: 19565925

6

Enhancing biological therapy through conditional regulation of protein stability.

Thorne SH. Thorne SH. Expert Rev Mol Med. 2010 Jan 12;12:e2. doi: 10.1017/S1462399409001331. Expert Rev Mol Med. 2010. PMID: 20064281 Review.

7

Next-generation oncolytic vaccinia vectors.

Thorne SH. Thorne SH. Methods Mol Biol. 2012;797:205-15. doi: 10.1007/978-1-61779-340-0_14. Methods Mol Biol. 2012. PMID: 21948478

8

High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases.

Yan W, Chang Y, Liang X, Cardinal JS, Huang H, Thorne SH, Monga SP, Geller DA, Lotze MT, Tsung A. Yan W, et al. Among authors: thorne sh. Hepatology. 2012 Jun;55(6):1863-75. doi: 10.1002/hep.25572. Hepatology. 2012. PMID: 22234969 Free PMC article.

9

Crosstalk between immune cell and oncolytic vaccinia therapy enhances tumor trafficking and antitumor effects.

Sampath P, Li J, Hou W, Chen H, Bartlett DL, Thorne SH. Sampath P, et al. Mol Ther. 2013 Mar;21(3):620-8. doi: 10.1038/mt.2012.257. Epub 2012 Dec 11. Mol Ther. 2013. PMID: 23229093 Free PMC article.

10

A rationally designed A34R mutant oncolytic poxvirus: improved efficacy in peritoneal carcinomatosis.

Thirunavukarasu P, Sathaiah M, Gorry MC, O'Malley ME, Ravindranathan R, Austin F, Thorne SH, Guo ZS, Bartlett DL. Thirunavukarasu P, et al. Mol Ther. 2013 May;21(5):1024-33. doi: 10.1038/mt.2013.27. Epub 2013 Feb 26. Mol Ther. 2013. PMID: 23439499 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

583 results

Search Page

Filters